INS and type 2 diabetes mellitus: In this real-world study, comparative effectiveness analyses showed that initiating Gla-300 or Deg-100 in uncontrolled insulin-naïve patients with T2D was followed by statistically significant and clinically relevant HbA1c reductions (− 1.70%) after 6 months, without significant differences between groups.